Welcome to our dedicated page for ESAB SEC filings (Ticker: ESAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ESAB Corporation filings document the regulatory record for an industrial manufacturer of welding, cutting and joining equipment and consumables. Its Form 8-K disclosures cover operating and financial results, material-event reporting, dividend and capital-structure matters, senior unsecured notes and related subsidiary guarantees.
Proxy and governance filings describe shareholder voting matters, director and officer changes, board committee assignments, executive compensation, director independence and related governance practices. The filing record also reflects public-company reporting following ESAB's 2022 registration as a standalone issuer.
ESAB Corporation agreed for its subsidiary to acquire all shares of Québec-based Eddyfi Holding Inc. and related entities for $1.45 billion in cash, subject to customary closing adjustments. After closing, Eddyfi and its subsidiaries will be wholly owned by ESAB’s purchasing subsidiary.
To help finance the deal, ESAB obtained a $1.0 billion 364‑day unsecured bridge loan commitment from JPMorgan Chase, which may be reduced by other financings completed before closing. The acquisition is expected to close in the middle of 2026, subject to regulatory approvals in multiple jurisdictions and other standard conditions.
ESAB also entered into private placements, agreeing to sell 175,000 shares of 6.50% Series A Mandatory Convertible Preferred Stock with an aggregate liquidation preference of $175.0 million (net proceeds about $171.5 million), including purchases by entities affiliated with Mitchell and Steven Rales, and 1,254,255 common shares for $142,985,070 (net proceeds about $140.1 million) at $114.00 per share.
ESAB Corp SVP and General Counsel Curtis E. Jewell reported an employee stock option exercise and related tax withholding. On January 26, 2026, he exercised options for 3,960 shares of common stock at $33.49 per share. ESAB withheld 2,512 shares at $120.475 per share to cover the exercise price and associated tax liability, and no shares were sold into the market for this purpose. After these transactions, Jewell directly owned 15,626 shares of ESAB common stock and indirectly held 354.75 shares through a 401(k) plan.
ESAB Corp director Martin Sebastien reported new equity awards. On January 1, 2026, he was granted 231 restricted stock units (RSUs), each representing a contingent right to receive one share of ESAB common stock. These RSUs vest in a single installment on January 1, 2027, meaning the shares are deliverable only if he remains eligible through that date.
On the same date, he was also granted 777 stock options to purchase ESAB common stock at an exercise price of $112.57 per share. The filing states that these options vested and became exercisable in full on the grant date. Following these transactions, Sebastien directly holds 231 RSUs and 777 stock options as reported derivative securities.
ESAB Corp director Martin Sebastien reported beneficial ownership of 595 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of ESAB common stock. These RSUs were granted to him in connection with consulting services previously provided to the company. The units will vest in three equal, annual installments beginning on October 1, 2026 and continuing through October 1, 2028, if the vesting conditions are met. The filing shows these RSUs are held directly.
ESAB Corp reported an equity transaction by its Chief Financial Officer on January 2, 2026. The filing shows that 986 restricted stock units (RSUs) were converted into an equal number of shares of ESAB common stock, reflecting the vesting of a prior equity award. In connection with this vesting, 537 shares of common stock were withheld by ESAB to cover the officer's tax liability at a price of $112.57 per share, and no shares were sold by the officer for this purpose.
After these transactions, the officer directly beneficially owned 26,404 shares of ESAB common stock. The RSU award referenced in the filing vests in three equal annual installments that began on January 2, 2025, with the remaining restricted stock units scheduled to vest on January 2, 2027.
ESAB Corp reported that one of its directors received 213 deferred stock units on 12/31/2025. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of the director's cash retainer for Board service, so they carry a price of $0 for this grant.
The deferred stock units vest immediately, meaning the director's right to the units is not subject to additional service conditions. However, the units will be settled in ESAB common stock only after the director separates from the company, aligning the director's compensation with the long‑term value of the stock.
ESAB Corp reported a routine equity compensation move for one of its directors. On 12/31/2025, the director received 263 deferred stock units, each representing a contingent right to receive one share of ESAB common stock. These units were issued in lieu of the director's cash retainer for Board service, effectively paying board fees in stock-based form rather than cash.
The deferred stock units vest immediately, but will only be settled in ESAB common stock after the director separates from the company. This structure aligns the director’s compensation with long-term shareholder value while deferring actual share delivery until service on the Board ends.
ESAB Corp reported that one of its directors received an equity-based award tied to board service. On 12/31/2025, the director was granted 54 deferred stock units, each representing the right to receive one share of ESAB common stock. These units were issued in lieu of the director’s cash retainer for serving on the Board.
The deferred stock units vest immediately, meaning they are fully earned on the grant date, but will be settled in ESAB common stock only after the director separates from the company. This aligns the director’s compensation more closely with ESAB’s long-term share performance without involving any open-market stock purchase or sale.
ESAB Corp reported that one of its directors received equity-based compensation in the form of deferred stock units. On 12/31/2025, the director acquired 213 deferred stock units, each representing a contingent right to receive one share of ESAB common stock with a par value of $0.001 per share.
These 213 deferred stock units were issued in lieu of the director's cash retainer for Board service, meaning the director chose stock-based pay instead of cash. The units vest immediately but will be settled in ESAB common stock only after the director separates from the company, aligning part of the director's compensation with long-term shareholder interests.
ESAB Corp director Mitchell P. Rales reported a grant of 493 shares of common stock in the form of deferred stock units on December 31, 2025, at a price of $0.00 per share. These units are payable only in common stock and will be settled after he leaves the Board, at the earlier of his death or January 31 of the second calendar year following his retirement.
After this grant, he directly holds 14,453 ESAB common shares. He also reports indirect holdings, including 3,355,765 shares through a single-member LLC, 4,816-share custodial accounts for his daughter for which he disclaims beneficial ownership, and 226,421 shares held by the Mitchell P. Rales Family Trust.